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Syndrome, and Progeria Share Common Systemic Involvement
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Abstract
Genetic mutations are becoming more deleterious day by day. Mutations of Genes named FBN1, AKT1, LMNA result specific protein malfunction that 
in turn commonly cause Marfan syndrome, Proteus syndrome, and Progeria, respectively. Articles about these conditions have been reviewed in 
PubMed and Google scholar with a view to finding relevant clinical features. Precise keywords have been used in search for systemic involvement of 
FBN1, AKT1, and LMNA gene mutations. It has been found that Marfan syndrome, Proteus syndrome, and Progeria commonly affected musculo-skeletal 
system, cardiovascular system, eye, and nervous system. Not only all of them shared identical systemic involvement, but also caused several very 
specific anomalies in various parts of the body. In spite of having some individual signs and symptoms, the mutual manifestations were worth mentio-
ning. Moreover, all the features of the mutations of all three responsible genes had been co-related and systemically mentioned in this review. There 
can be some mutual properties of the genes FBN1, AKT1, and LMNA or in their corresponding proteins that result in the same presentations. This study 
may progress vision of knowledge regarding risk factors, patho-physiology, and management of these conditions, and relation to other mutations.
Keywords: Genetic mutation; Marfan syndrome; Proteus syndrome; Progeria; Gene FBN1; Gene AKT1; Gene LMNA; Musculo-skeletal system; 
Cardiovascular system; Eye; Nervous system (Source: MeSH, NLM).
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Introduction
The haploid human genome consists of 3 billion nucleotides 
but changes in one single base pair can result in dramatic phy-
siological malfunctions.1 Mutations are changes in the genetic 
sequence at different levels that cause diversity among orga-
nisms.2 This can be happened by way of a number of factors.
Mutation is common in all types of organisms which is chie-
fly classified in three types; deleterious mutation with harmful 
effect upon host, neutral mutation with no effect, and advan-
tageous mutation for welfare of the organism. But, most of the 
non-neutral mutations are deleterious.2-3
If a deoxyribonucleic acid (DNA) repair mechanism fails, the 
physiological consequences of a mutation are quite inconstant, 
ranging from single cell death or cell carcinoma to hereditary 
genetic outcomes. Mutations in germline cells of human ge-
nerally produce inheritable consequences, while mutation in 
somatic cells of human ordinarily only have outcomes affecting 
the individual in which the mutation occurs (National Coun-
cil for Science and the Environment, Washington, DC. Available 
from: http://www.eoearth.org/view/article/159530/, updated 
2014 April 10, cited 2014 April 18).
Every cell, in order to function properly, depends on thousands 
of proteins to function in the right places at the right times. 
Changes in DNA caused by mutation can cause errors in protein 
synthesis, creating partially or completely non-functional pro-
teins which in combination ultimately could result in genetic 
disorders.4
Records in human mutation databases are increasing day by 
day.5 Even about one hundred thousand diseases showed as-
sociation with mutation of only 3,700 genes.6 Around 300 new 
"inherited disease genes" (and about 10,000 new mutations) 
are added to the record book in a year.7 The Human Gene Mu-
tation Database (HGMD) is a complete assortment of germline 
modifications in nuclear genes containing over 141,000 muta-
tions identified in more than 5,700 different genes up to June 
2013.8 The first genetic mutation was reported in the year 1977 
in HGMD Professional database with a maximum entry of 13,490 
in 2013. Among the entries Missense/Non-sense mutations are 
more than 82,000 (Human Gene Mutation Database. Available 
from: http://www.hgmd.cf.ac.uk/ac/hahaha.php, updated 2014 
April 12, cited 2014 April 18).
Besides some common disorders, mutations sometimes re-
port some rare diseases like progeria, Marfan syndrome (MFS), 
Mandibuloacral dysplasia (MAD), Loeys–Dietz syndrome, Wol-
ff-Parkinson-White Syndrome, Ehlers–Danlos syndrome, Proteus 
syndrome, Cantu syndrome, etc. Some of them shows same 
prevalence pattern, some shows nearly same clinical featu-
res and presentations. But, in spite of knowing about affected 
proteins of mutation, the actual pathogenesis and course of 
the disease is not clear. Over a decade have passed after the 
completion of human genome project but the gene mutation 
diseases’ treatment is still in a labyrinth. For a better treatment, 
pathogenesis should be discovered and to look through it, it is 
needed to track the effects of affected proteins which is reflects 
by common manifestations in different systems of the body.
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The reason for selecting these three genes is to study their little 
known pathophysiology. The documented similarities between 
them were wanted to compile in a review.
Search Strategy and Selection Criteria
A literature search was conducted using Google Scholar, Pub-
Med (Medline), The Human Gene mutation Database, and 
Genetic Home of US national Library. Key word combinations 
included “Marfan syndrome clinical features”, “Proteus syn-
drome features”, “Progeria syndrome features”, “Gene FBN1 
mutation”, “Gene AKT1 mutation”, Gene LMNA mutation”. One 
hundred thirty five articles were chosen for review. The inclu-
sion criteria incorporated the articles on disease case reports, 
databases, review papers and original papers. The exclusion 
criteria were unavailability of any full article, unclear presen-
tation, non-relevant study and reports of different languages 
other than English. The common features were assembled into 
this narrative review. This review follows the Preferred Repor-
ting Items for Systematic Reviews and Meta-Analysis (PRISMA) 
Statement.9
Gene FBN1, AKT1, LMNA and associated proteins
FBN1 gene is located on chromosome 15q15-21.3.10 This gene 
is 200kb and divided into 65 exons.11 It encodes fibrillin-1,10 
a large extracellular matrix glycoprotein which assembles in 
extracellular matrix. In this matrix, fibrillin-1 binds to other mo-
lecules of it and other proteins to form 10-12 nm threadlike 
filaments called microfibrils.12 Microfibrils are main constituent 
of elastic fibers responsible for stretching and supporting many 
tissues of the body. It also store a protein called transforming 
growth factor beta (TGF-ß), a critical growth factor which helps 
in proliferation, differentiation, motility, and apoptosis of cells. 
Microfibrils help to regulate the availability of TGF-ß, which is 
inactivated when stored in microfibrils and activated when 
released (National Library of Medicine, NLM, Genetic - FBN1. 
Available from: http://ghr.nlm.nih.gov/gene/FBN1, updated 2014 
April 12, cited 2014 April 18).
AKT1 is located on chromosome 14q32.32. It is also known as 
PKB, RAC-PK. This gene initiates for a protein called AKT1 kinase 
which is responsible for signaling in the cells for its growth, 
multiplication, stability and apoptosis (NLM, Genetic - AKT1. 
Available from: http://ghr.nlm.nih.gov/gene/AKT1, updated 2014 
April 12, cited 2014 April 18).
In mouse, it is found that, during apoptosis, Akt is cleaved by 
caspases and mediates survival signals for protection against 
apoptosis.12 Signaling involving AKT1 kinase also appears to be 
vital for the usual growth and function of the nervous system. 
It has a role in cell-to-cell communication among neurons, neu-
ronal survival, and the formation of memories. The AKT1 gene 
belongs to a class of genes known as oncogenes.13
The LMNA gene, also known as lamin A/C is located on the long 
(q) arm of chromosome 1 at position 22. More precisely, the 
LMNA gene is located from base pair 156,082,545 to base pair 
156,140,088 on chromosome 1.14,15 This gene translates some 
slightly diverse proteins called lamins; among them lamin A 
and lamin C are common in the most body cells. These proteins 
have an almost duplicate sequence of amino acids. The small 
difference in the sequence makes lamin A longer than lamin C 
due to encoded by an extra exon.15 Lamins A and C are structu-
ral proteins called intermediate filament proteins that provide 
stability and strength to cells. Lamins A and C are scaffolding 
(supporting) components of the nuclear envelope. Specifically, 
these proteins are located in the nuclear lamina where it regu-
lates the movement of molecules into and out of the nucleus. 
Between lamin A and C, only the lamin A protein must be 
processed from prelamin A before becoming part of the lamina 
(NLM, Genetic - LMNA. Available from: http://ghr.nlm.nih.gov/
gene/LMNA, updated 2014 April 12, cited 2014 April 18).
Mutation of the Gene and diseases
Mutation in the Gene FBN1 causes MFS, Ectopia lentis, 
Shprintzen-Goldberg syndrome, and Hereditary aortic aneu-
rysm. A mutation in the FBN1 gene has also been identified 
with Weill-Marchesani syndrome, stiff skin syndrome, neo-
natal MFS,10,16 Juvenile idiopathic arthritis, and acromicric or 
geleophysic dysplasias.17
When mutation occurs in AKT1 gene, it causes Proteus syndro-
me. AKT1 gene is an oncogene which can create breast, ovarian 
and colorectal cancer after mutation and may have some asso-
ciation with schizophrenia (NLM, Genetic - AKT1. Available from: 
http://ghr.nlm.nih.gov/gene/AKT1, updated 2014 April 12, cited 
2014 April 18). Mutation in gene AKT1 may also causes endome-
trial carcinoma,18 bladder tumors,19 squamous cell carcinoma of 
lung,20 metastatic thyroid cancer,21 hepatocellular carcinoma, 
and acute leukemia,22 and many other tumors of the body.33
Mutations in the LMNA gene are related to a number of disea-
ses, including Hutchinson-Gilford progeria syndrome (HGPS), 
limb girdle muscular dystrophy, familial partial lipodystrophy, 
Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, 
Charcot-Marie-Tooth disease. The mutated gene of lamin A that 
causes HGPS commonly known as progerin.23,24 Loss of lipid 
level, type-2 Diabetes mellitus, Dispersed Leukomelanodermic 
Papules, mandibuloacral dysplasia, lethal restrictive dermopa-
thy, and atypical progeroid syndrome (APS) are also result of 
mutation in LMNA gene.128
In latter sections, MFS due to FBN1 mutation, Proteus syndrome 
due to AKT1 mutation and Progeria syndrome due to LMNA muta-
tion is going to be discussed for common systemic involvement.
Common systemic involvement of these 
gene mutations
Musculo-Skeletal system
The phenotypes of MFS caused by FBN1 mutation, Proteus syn-
drome caused by AKT1 mutation and Progeria caused by LMNA 
mutation commonly results musculo-skeletal system abnormality.
In MFS, most of the visible signs are related to the skeletal 
system. Persons may have dolichostenomelia, arachnodactyly, 
abnormal indentation or protrusion of the sternum, stooped 
shoulders, malocclusions,25 abnormalities of the spine,26 pre-
sence of osteopenia (mainly in Marfan children), inadequate 
bone acquisition.28 The diagnosis of MFS relies on defined clini-
cal criteria (Ghent nosology), outlined by international expert.29 
MFS causes the femoral head protruding into abnormally deep 
hip sockets (protrusio acetabuli).25 Protrusio acetabuli is a crite-
rion for the diagnosis of MFS. If acetabuli is protruded for long 
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time, it can cause anomaly in the hip joint and acetabular line.19 
MFS also shows vascular smooth muscle cell apoptosis.30,31
In Proteus syndrome, skeletal abnormalities are the most fre-
quent findings.35 Proteus syndrome shows megaspondylodys-
plasia,32 and cranio-facial abnormalities.33-35 Abnormal bony ed-
ges, bony invasions, joint immobility, and loss of overlying soft 
tissues have been reported in cases of it.33,34 Manifestations of 
Proteus syndrome include large sized finger in association with 
permanent medial or lateral deflection of one or more fingers, 
fusion of the bones in fingers or toes, or webbing of the soft 
tissues between the digits.35
In this condition, overgrowth of muscle and abnormally lar-
ge muscle group with asymmetric muscle development are 
found.36 Some smooth Muscle shows hyperplasia.37,38
In Progeria caused by LMNA mutation, skeletal defects inclu-
de severe osteolysis,39 hypoplasia, dysplasia, and pathological 
fractures. It can cause severe alterations in osteogenesis, in-
cluding craniofacial disproportion with a “plucked bird” appea-
rance,40,43 short dystrophic clavicles, and thin and high pitched 
voice that may also occur.40,42,43 It also cause resorption of the 
clavicle,41-43 microvascular inadequacy, matrix abnormalities, 
bony maldevelopment, abnormally broad metaphyses and epi-
physes, avascular necrosis of the femoral head.42 The patients 
also have an extremely aged appearance and the limbs are 
usually thin and may be associated with stiff joints, and coxa 
valga. They also demonstrate “horse riding” stance and wide 
based shuffling gait.43 The ranges of motion for wrist, ankle, 
and hip rotation may decrease than normal.41 There is chance 
of stooped shoulders, calcaneovalgus, genu valgum, kyphosis, 
or calcaneo varus.41,43 The muscle strength is preserved.41,44,45
More specifically, MFS and Progeria both cause abnormal chest 
cavity where MFS can cause pectus excavatum or pectus cari-
natum,25 and Progeria may cause pyriform thorax with tapering 
of ribs.40-43 Osteopenia occurs in both of the cases which is axial 
or peripheral in MFS,37 and generalized in progeria.40-43 MFS also 
share pathological fracture and vascular smooth muscle cell de-
fect with progeria.28,31,40,44 On the other hand, Proteus syndrome 
and progeria both have dental abnormalities where Proteus sy-
ndrome may cause alveolar dental ridges,35 and Progeria cause 
dental crowding with delayed teeth eruption.41-43
Some other regular features of musculo-skeletal system which 
are common in all these three mutations are discussed in the 
Table 1.
Cardio-vascular system
The MFS, Proteus syndrome and Progeria commonly cause car-
dio-vascular system abnormalities.
In MFS, cardio-vascular systems, usually diagnosed in young 
age is associated with poor prognosis.46 Cardiac arrhythmias, 
sudden cardiac death, endocarditis,47-49 are also cardiovascular 
manifestations of the MFS. Mitral Valve Prolapse is indicated as 
a useful diagnostic tool.47,50,51 The cardiovascular manifestations 
are the leading cause of death in MFS.51 MFS can also cause 
dilatation of the main pulmonary artery (MPA), dysfunction of 
the myocardium due to microfibrillar defect,51 abnormal rea-
ding on an electrocardiogram (ECG) but aortic wave reflection 
is not elevated in MFS.51-52 Infantile MS presents high morbidity 
with mitral regurgitation and heart failure.53 Clinical presenta-
tions of these manifestations comprise short breath, cardiac 
palpitations, abnormal heartbeats or angina pectoris with pain 
radiating to the back, shoulder, or arm.52 Myocardial infarction 
and bacterial endocarditis are some cardiac causes of death.54 
In vascular system, there can be many types of defects in ar-
terial wall including calcification. Rarely it shows axillary artery 
aneurysm.55,56
Proteus syndrome affects cardiac system less but sometimes 
it reports complex congenital heart disease and some myocar-
dial abnormalities.57-59 Multiple superficial, visceral and vascular 
abnormalities are present in Proteus syndrome.60 Vascular mal-
formations have also been reported in this case with variety of 
types. They grow proportionately with the patient: they never 
regress, but they can expand.33 It can also cause cerebral vas-
cular malformations,61 vascular tumors, portwine stains (PWS), 
and venous anomalies (varicosities, prominent veins).62
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Involvement of Marfan syndrome 34,35,39 Proteus syndrome 42-45,47 Progeria 48-52,54
Extremities Long and slender limbs, finger, toes, 
wrists that grows disproportionally. Flat 
feet, Hammer toes.
Macrodactyly of hands & feet. Clinodac-
tyly, Syndactyly, Polydactyly of fingers 
and toes. 
Hypoplasia and pathology of arm, leg, finger, 
and toe. Narrow and thin shaft of femur and 
humerus. Resorption of terminal phalanges and 
dystrophic nails. 
Spine Abnormal curvature of spine (scoliosis), 
kyphoscoliosis and other abnormalities. 
Vertebral dysplasia, asymmetry and en-
largement.
Severe scoliosis and decreased spinal flexion.
Skull and fa-
cial
High palate, small jaw Calvarial thickening, frontal bony promi-
nence, macrocephaly, hyperostoses of 
the skull. Nasal bridge deformity, exter-
nal auditory canal overgrowth.
Persistent open fontanelles, cranio-facial dispro-
portion, short and sculptured nose, large bald 
head, small jaw.
Joint Abnormal flexion, pain, early osteoar-
thritis.
Abnormal flexion Avascular necrosis of joint bones, Hip disloca-
tion.
Motion Limited. Limited. Limited.
Muscle Atrophy and hypoplasia. Rarely. Atrophy may present in quadri-
ceps femoris.
Sometimes atrophy.
Table 1. Common Features Found in Marfan Syndrome, Proteus Syndrome, and Progeria Involving Musculo-skeletal System.
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In HGPS, the principal factor affecting mortality in individuals 
is cardiovascular disease. The description of the cardiovascular 
features of HGPS has proven to be quite consistent,63 that inclu-
de prominent atherosclerosis and calcification of coronary arte-
ries and others. The coronary artery disease leads to ischemic 
changes in the myocardium, including well-defined infarcts. In 
addition, it may also cause narrowing of the small intramural 
arteries, which may contribute to myocardial fibrosis.64 Chest 
x-rays shows cardiac enlargement and the electrocardiogram 
(ECG) shows right atrial hypertrophy sometimes.65 Sonographic 
and ECG evidence of myocardial ischemia is not common initia-
lly, but after a few years, echocardiograms and carotid Doppler 
sonography may show hypertrophy of the intimal layer of the 
internal carotid artery. Atherosclerotic changes, tricuspid valves 
with increased echo texture, left and right atrial dilatation, cal-
cific aortic stenosis, cardiomegaly, and hypercholesterolemia 
are also seen in progeria.65,66 Death from cardiac complications 
at an average age of 14 years is usually preceded by angi-
na pectoris and myocardial infarction,66 caused by progressive 
atherosclerotic disease.66 Children may die of myocardial infarc-
tion when they are found with diffuse loss of vascular smooth 
muscle and endothelial cells throughout their coronary arteries 
and replacement by fibrosis and adventitial thickening.67 If an 
old man has typical HGPS, he shows refractory congestive heart 
failure due to arteriosclerotic heart disease and hypertension, 
and also has arteriosclerosis obliterans.68 Sometimes loss of 
vascular smooth muscle cells (VSMCs) in the great vessels, ve-
ins, smaller arteries, and arterioles is seen in a case of proge-
ria. There is spontaneous breaks in elastic structures,63,67 and 
prominent adventitial fibrosis too.69 Vascular atherosclerotic 
changes may cause subdural hemorrhage leading to death in 
some cases. Small collagen fibrils in the atherosclerotic intima 
and media with extensive loss of mural smooth muscle cells 
in the aorta are also reported.70 Progeria can cause cerebral 
infarction and renal infarction.62
More specifically, MFS and Progeria both cause mitral valve 
calcification and increased echo texture.51,63-65 MFS also cause 
mitral valve prolapse, regurgitation, fluttering of mitral leaflet,47 
and severe rheumatic mitral stenosis.49 MFS and Proteus syn-
drome also share ventricular hypertrophy and dysfunction,50,51,65 
systolic and diastolic abnormality,51,66 cardiac murmur, angina 
pectoris, congestive cardiac failure and myocardial infarction 
in common.52,54,66 On the other hand, Proteus syndrome and 
Progeria both can cause thickening of myocardial septum,59,65 
cardiomyopathy, myocardial fibrosis and mass,59,66 and abnor-
mality in vascular endothelium.33,63,67
Some other regular features of cardio-vascular system which 
are common in all these three mutations are discussed in the 
Table 2.
Eye
The MFS, Proteus syndrome and HGPS commonly affect eye.
In MFS, eye complications such as lens dislocation or ectopia 
lentis occur in more than half the people who have MFS, earlier 
in women,73 and in some cases it is progressive (Mayo Clinic 
- MFS. Available from: http://www.mayoclinic.org/diseases-con-
ditions/marfan-syndrome/basics/complications/con-20025944, 
updated 2014 April 07, cited 2014 April 18).71,72 Glaucoma is 
also common at a younger age which can damage the op-
tic nerve.74,75 Sometimes MFS reports phthisis bulbi, bilateral 
or unilateral blindness.74-76 The another ocular abnormality is 
enlargement of the globe, presumably caused by stretching 
of the tunica scleralis, and the zonular fibers.71 Some studies 
suggest prevalence of retinal detachment and some suggest 
prevalence of ectopia lentis. This variation recommend other 
genotype–phenotype relationships exist which may account for 
differences in ocular manifestations of MFS.73
The ocular manifestations of a Proteus syndrome are due to se-
vere maldevelopment and malfunction of the neuroretina. Epi-
bulbar tumors are recorded most commonly,76 while periorbital 
exostoses are infrequent,77,81 extraocular tendons and posterior 
segment involvement can be seen in a case of Proteus syn-
drome presenting with vertical strabismus secondary to a fi-
brous tumor within the superior oblique tendon.78,79 Sometimes 
myopia associates with mild calcific band, abnormal vitreous 
structure, vitreous hemorrhage, and a resolved serous retinal 
detachment in a patient of Proteus syndrome.81 The oncogene 
of Proteus syndrome may show some overgrowth syndromes in 
eyes.81 Sometimes epibulbar cystic lesions with nodular gliosis 
are also reported in this condition.81
In Progeria, loss of eye brows and eye lashes with prominent 
eyes is common in the early childhood.43,83 Eyelid retractions, 
lagophthalmos, superior sulcus deformity, upper lid lag in 
down gaze, and poor pupillary dilatation are also reported. 
In the HGPS, eyes look prominent (pseudoproptosis) probably 
due to lid retraction, although there is no true proptosis. Su-
perior sulcus deformity may also occur due to lipodystrophy of 
the orbital fat. Patients with HGPS do not develop other ocu-
lar features associated with aging, such as presbyopia, arcus 
senilis or age-related macular degeneration. Other rare ocular 
Traits Marfan syndrome 56,60,64,65 Proteus syndrome 66-68,71 Progeria 72-75,77,79
Aorta Aortic aneurysm, regurgitation, Aortic 
rupture, stiffness, dissection. Dilation 
of ascending aorta
Aortic malformation Atherosclerosis of aorta, dilated ascending aorta, 
thickening and calcification of aortic valve, loss of 
vascular smooth muscle cell in descending aorta.
Heart 
conduction
Arrhythmia Thickening of myocardial septum 
may affect conduction.
ECG shows giant P waves
Contractile 
dysfunction
Present Thickening of myocardial septum 
may affect contraction.
Present
Hyperplasia of 
arterial wall
Seen Seen Seen
Table 2. Common Features Found in Marfan Syndrome, Proteus Syndrome, and Progeria Involving Cardio-vascular System.
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manifestations of the HGP syndrome are bands of skin running 
from the upper lid to the cornea, senile ectropion, ptosis with 
Marcus-jaw-winking phenomenon, dry-eye syndrome, and iri-
docorneal adhesions.83-85
More specifically, MFS and Proteus syndrome both cause optic 
nerve damage,74,75 and the former can also cause hypoplasia and 
papilledema of optic nerve.79,82 Proteus syndrome and Progeria 
both have features of nystagmus or nystagmoid movements.76,83
Some other regular features of eye which are common in all 
these three mutations are discussed in the Table 3.
Nervous system
The MFS, Proteus syndrome and Progeria commonly cause ner-
vous system abnormalities.
In MFS, the most common and classic neurological manifes-
tations are cerebrovascular.86,87 Patients with MFSmay have a 
subarachnoid hemorrhage or intracranial aneurysm,88 and near 
total erosion of a pedicle. Dural ectasia can be added to the list 
of pleiotropic manifestations of the MFS.89 There is probability 
of heterogeneous involvement of other components of Extra 
Cellular Matrix microfibrils at the basis of this cerebrospinal 
manifestation.90,91 Dural ectasia with bone erosion which are 
often reported in this condition can be associated with seve-
re postural headache secondary to spontaneous intracranial 
hypotension resulting from cerebrospinal fluid leaks caused 
by underlying fibrillinopathy.91-93 It is recognized as a potential 
complication in children with MFS,93 and also reported with 
severe back pain in adults.94,95 When neural symptoms or fin-
dings do occur they may be related to stretching and traction 
mechanisms.91
Proteus syndrome often presents hemimegalencephaly with 
high incidence of other brain anomalies.96,97 These include 
hypoplasia of the corpus callosum and crus cerebri, grey and 
white matter calcification and cortical migration/organisational 
disorders.96 Neurologic sequelae caused by vertebral anoma-
lies are reported too.98,99 Proteus syndrome has evidence to 
develop pinealoblastoma, Dandy-Walker malformation, cor-
pus callosal abnormalities, periventricular calcification, hypo-
dense periventricular white matter, and mental deficiency. 
Hemimegalencephaly is not a finding in this entity; reported 
abnormalities include hydrocephalus, porencephaly, cerebral 
calcifications, and polymicrogyria. Additional Central Nervous 
System (CNS) findings are thought to be the sequelae of vascu-
lar dysplasia, and include infarcts, atrophy, porencephaly, and 
calcifications.100 Some neurological defects like hydrocephaly, 
lissencephaly, partial agenesis of the corpus callosum are also 
reported with the Proteus syndrome.101 It may cause paraspi-
nal hamartoma.99 Protuberance of the skull,102 structural and 
functional asymmetry of the central nervous system,103 hydro-
cephalus and mental retardation are also some features of pro-
teus syndrome.102 Epilepsy and ohtahara syndrome is diagno-
sed in children affected by Proteus syndrome associated with 
infantile spasms, myoclonia, and partial epilepsy in newborn 
infants.97
In HGPS, diffuse encephalopathy, and Pseudotumor cerebri has 
been reported.41 Even a mild head injury can cause intracranial 
pathology in a progeria patient. Progressive atherosclerosis of 
intracranial vessels is responsible for formation of the hema-
tomas in this condition.104,105 In progeria, motor and mental de-
velopment is normal, as are intelligence.106 But there may be a 
low-frequency conductive hearing loss.107
There is chance of Peripheral neuropathy,108 cerebrovascular di-
sease of aging in this age related disease, progeria.109
More specifically, MFS and Progeria both may cause heada-
che,91-93,104 and do not have any mental retardation.105,106 MFS 
and Proteus syndrome both have spinal cord involvement whe-
re MFS may cause spinal Cerebro-spinal Fuild (CSF) leaks, spi-
nal arachnoid diverticula, trauma, and congenital enlargement 
of spinal canal,90,91,94 and Proteus syndrome may cause spinal 
stenosis, paraspinal tumor, and spinal cord compression.98,99 
On the other hand, seizures in seen in both Proteus syndrome 
and Progeria.100,102,104
Some other regular features of nervous system which are com-
mon in all these three mutations are discussed in the Table 4.
Not shared systemic phenotypes
MFS often presents spontaneous recurrent or bilateral pneumo-
thorax,110 congenital malformations,111 pneumonia, bronchiecta-
sis, emphysematous bullae, upper lobe fibrosis, aspergilloma 
and other lung related disorders.110-114 Patients may have lower 
values of Forced Vital Capacity and Total Lung Capacity and 
other spirometric values,115 with a decrease in carbon monoxi-
de transfer factor, and lung elastic recoil.115 Other Lesser known 
areas of involvement are renal and dermatologic.111,117
Traits Marfan syndrome 81-86 Proteus syndrome 87,88,90-92 Progeria 94,96
O p t h a l m i c 
anthropome-
tric measures
Increased axial length Overgrowth syndromes can cause 
length or distance abnormality
Reduced horizontal palpebral fissure length, inter 
pupillary distance, inner canthal distance and outer 
canthal distance.
R e f r a c t i v e 
errors
Myopia and astigmatism High myopia Myopia or hyperopia
Cornea Unilateral corneal opacities, flat cornea Keratopathy Corneal dryness, opacities, clouding and keratopathy.
Retina Detachment or tear in the retina Abnormal retinal pigment, dysgene-
sia. Diffuse retinal disorganization 
and chorioretinal mass
Retinal arteriolar narrowing, tortuosity, Retinal angios-
clerosis and retinopathies.
Cataract Seen Seen Seen
Strabismus Present Present Present
Table 3. Common Features Found in Marfan Syndrome, Proteus Syndrome, and Progeria Involving Eye.
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In proteus syndrome, Patients most commonly show bilate-
ral ovarian serous cystadenomas, mesothelioma, and papi-
llary carcinoma of the thyroid.118 Connective tissue nevus and 
brownish epidermal nevus in various region,33,119 benign and 
malignant tumors and hamartomas are also seen in proteus 
syndrome. Commonly encountered tumors include hemangio-
mas, lymphangiomas, lipomas, epithelial tumor of the female 
genital tract, testicular and paratesticular tumors.119 Four types 
of abnormal fat may occur in Proteus syndrome: lipomas, lipo-
hypoplasia, fatty overgrowth, and partial lipohyperplasia. There 
may be Fatty matter infiltration, Subependymal nodules, and 
Parenchymal distortion. Other rare tumors include Meningioma, 
Parotid monomorphic adenoma, Astrocytoma, Optic nerve tu-
mor, Pinealoma, Breast intraductal papilloma, Leiomyoma, En-
dometrial carcinoma, and giant kidney cysts. Multiple tumors 
in the same patient are often seen in proteus syndrome,33 with 
distal renal tubular acidosis and nephrocalcinosis, dilated and 
tortuous renal veins with possible calcifications.120
Progeria can cause low weight, vertical midline groove in the 
chin, sclerodermatous skin, reduced subcutaneous fat,121 promi-
nent superficial veins, dyspigmentation, and alopecia of skin.122
A progeria case may present some biochemical abnormalities like 
hypoaminoacidemia, hyperaminoaciduria, increased radioactive 
Iodine uptake in thyroid, and other abnormalities in blood.123
Progeria patients may be seen to sleep with open eyes, labial 
weakness, and nasal speech affecting speech fluency.43 Loca-
lized glomerulosclerosis, tubular atrophy, mesengial matrix 
growth, papillary adenoma are shown in older cases.124
Vision of future research
The genes responsible for the three diseases are not known to 
interact, so the possibility of mutation in any of them affecting 
functions of the other two is quite unlikely. However, recent stu-
dies suggest that mutations in the penultimate exon of FBN1 (in 
the 3' terminus) give rise to a neomorphic phenotype leading to 
a condition known as Wiedemann-Rautenstrauch syndrome,125 a 
rare disorder characterized by overlapping of the clinical mani-
festations of both marfan's syndrome and progeroid syndrome. 
It has been suggested that, this rare subgroup of MFS, compri-
sed of congenital lipodystrophy, a neonatal progeroid appea-
rance,126 and a progressive clinical course with early lethality, 
should be referred to as marfanoid-progeroid syndrome.127 
Evidence of involvement of any mutation in the LMNA gene, 
the one associated classical progeria has not been unveiled till 
now.125 Any association of mutation in the AKT1 gene with the 
aforementioned circumstances is yet to be explored.
Conclusion
Genetic mutation is day by day increasing entries in the disea-
se directory and started threatening the mankind like never be-
fore. MFS, Proteus syndrome, and Progeria are one of the most 
recognized mutation related diseases caused by mutation of 
FBN1, AKT1, and LMNA genes correspondingly. If we go through 
the Clinical features and systemic involvements of these mu-
tations, we can find common involvement of musculo-skeletal 
system, cardiovascular system, eye, and nervous system. In 
musculo-skeletal system, deviations of spinal curvature, ab-
normalities in the extremities, skull, and facial bones are re-
ported in all the three mutations. All cause abnormal flexion 
and limited range of motion of joints. In cardiovascular system, 
all the three mutations have reported abnormality of the aor-
ta and cardiac conductive system. Contractile dysfunction of 
heart and hyperplasia of arterial wall have been seen in com-
mon too. In case of eye, MFS, Proteus syndrome, and progeria 
share many clinical features. All cause cataract, strabismus, 
and refractive errors along with same kind of retinal and cor-
neal abnormalities. These mutations also have described some 
common nervous system features where all cause meningeal 
abnormalities, neurovascular abnormalities, congenital and de-
velopmental abnormalities. Stroke has been seen in all the 
three cases too. Though the mentioned mutations have certain 
individual unique characteristics too, the outcomes indicate 
that there can be some relation among the proteins related to 
these mutations, or among the genes of which modification 
occurs. The results of this review will enrich the field of genetic 
research and medicine. Furthermore, this study can help to 
acknowledge the reported sign & symptoms of three diseases 
and inter-relation among them. Additionally, it is recommen-
ded to have more attention in this field.
Traits Marfan syndrome 97,98,100,102-107 Proteus syndrome 111-113 Progeria 50,116,118
Neurovascular Cerebral artery aneurysm, dissection, 
hemorrhage and ischemia.
Vascular dysplasia, infarction 
and hemorrhage
Transient ischemia, stenosis of cerebral, vertebral and 
basilar arteries, arteriosclerosis, atherosclerosis, Epidural 
hematoma
Stroke Seen Seen Seen
Meninges Dural ectasia, hernia of meninges or 
meningocele
Meningioma Meningeal hematoma.
Congenital CNS 
abnormality
Present Present Present
Developmental 
CNS abnormality
Present Present Present
Table 4. Common Features Found in Marfan Syndrome, Proteus Syndrome, and Progeria Involving Nervous System.
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